NantHealth

News

NantCell Announces New Celgene Investment

Immunotherapy Company Will Present Findings at the JP Morgan Healthcare Conference in San Francisco on January 7thSecond Round Crossover Funding Brings Celgene’s Investment to $105M in NantCell Valued at $4 BillionCurrently Enrolling Patients in Advanced...

Media Contact

Jen Hodson
NantWorks
Telephone: 562-397-3639
Email: Press@NantHealth.com